TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Pharmetheus AB
Closing information (x1000 NOK)
| Closing information | 2024/11 | 2023/11 | 2022/11 |
| Turnover |
193,348
|
196,637
|
141,806 |
| Financial expenses |
148
|
106
|
90 |
| Earnings before taxes |
15,944
|
50,476
|
36,439 |
| EBITDA |
16,433
|
51,026
|
36,950 |
| Total assets |
87,361
|
105,140
|
69,546 |
| Current assets |
69,459
|
101,833
|
68,283 |
| Current liabilities |
37,093
|
41,472
|
28,126 |
| Equity capital |
45,872
|
59,225
|
37,318 |
| - share capital |
64
|
65
|
60 |
| Employees (average) |
82
|
71
|
61 |
Financial ratios
| Fiscal year | 2024/11 | 2023/11 | 2022/11 |
| Solvency |
52.5%
|
56.3%
|
53.7% |
| Turnover per employee |
2,358
|
2,770
|
2,325 |
| Profit as a percentage of turnover |
8.2%
|
25.7%
|
25.7% |
| Return on assets (ROA) |
18.4%
|
48.1%
|
52.5% |
| Current ratio |
187.3%
|
245.5%
|
242.8% |
| Return on equity (ROE) |
34.8%
|
85.2%
|
97.6% |
| Change turnover |
-1,133
|
43,035
|
42,797 |
| Change turnover % |
-1%
|
28%
|
43% |
| Chg. No. of employees |
11
|
10
|
6 |
| Chg. No. of employees % |
15%
|
16%
|
11% |
Total value of public sale
| Fiscal year | 2024/11 | 2023/11 | 2022/11 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.